Bionano Genomics, Inc.
BNGO
$4.08
-$0.02-0.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -135.78M | -204.10M | -226.79M | -232.49M | -227.28M |
| Total Depreciation and Amortization | 15.42M | 13.42M | 13.73M | 13.91M | 13.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.28M | 89.73M | 98.31M | 108.17M | 98.88M |
| Change in Net Operating Assets | -4.11M | -4.23M | -6.14M | -14.77M | -14.60M |
| Cash from Operations | -92.20M | -105.18M | -120.90M | -125.18M | -129.92M |
| Capital Expenditure | -848.00K | -923.00K | -1.36M | -1.69M | -2.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | 0.00 | 0.00 | 96.00K | 96.00K | -31.25M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.32M | 55.19M | 56.48M | 25.75M | 124.79M |
| Cash from Investing | 15.47M | 54.27M | 55.22M | 24.16M | 91.14M |
| Total Debt Issued | 18.00M | 18.00M | -- | -- | -- |
| Total Debt Repaid | -73.06M | -70.05M | -45.71M | -9.05M | -44.00K |
| Issuance of Common Stock | 49.03M | 51.84M | 58.02M | 57.83M | 46.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 56.94M | 57.69M | 65.03M | 65.04M | -1.16M |
| Cash from Financing | 50.91M | 57.48M | 77.34M | 113.82M | 45.48M |
| Foreign Exchange rate Adjustments | 45.00K | 11.00K | 3.00K | 65.00K | 103.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.77M | 6.58M | 11.66M | 12.86M | 6.80M |
